Streetbeat News

Products Services

NVAX

Novavax announced that the European Commission has granted marketing authorization for its updated 2024-2025 Nuvaxovid COVID-19 vaccine. This follows a positive opinion from the EMA's Committee for Medicinal Products for Human Use.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:03 am

CANF

The FDA has granted Orphan Drug Designation to Can-Fite Biopharma's Namodenoson for the treatment of pancreatic cancer. This designation is significant as it provides certain benefits to the company, including market exclusivity and potential tax credits.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:02 am

PLL

Piedmont Lithium has received a Mine Operating Permit from the Minerals Commission of Ghana for the Ewoyaa Lithium Project, a joint venture in Ghana.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:55 am

CLSD

Clearside Biomedical's ODYSSEY Phase 2b trial of CLS-AX for neovascular age-related macular degeneration achieved its primary and secondary outcomes, maintaining stable visual acuity and anatomical control over 9 months with a positive safety profile. 67% of participants did not require additional treatment for up to 6 months, reducing treatment burden by 84%.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:36 am

OCGN

Ocugen announced that the US FDA has lifted the clinical hold on their investigational new drug application for the Phase 1 clinical trial of OCU200, a treatment for diabetic macular edema.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:32 am

FXI

SPY

USO

U.S. markets closed higher as tech stocks gained, while China's markets plunged due to profit-taking and lack of new stimulus. European markets edged up slightly, and crude oil prices rose amid Middle East tensions.

Portfolio Pulse from Akanksha Bakshi

October 09, 2024 | 10:32 am

BABA

BIDU

JD

MCHI

SPY

TCEHY

Ray Dalio warns about the complexities of investing in China due to shifting economic policies and government control. Despite recent optimism, Chinese stocks have faced volatility, impacting major indices and tech giants.

Portfolio Pulse from Benzinga Neuro

October 09, 2024 | 10:28 am

BYDDF

BYDDY

BYD aims to sell 100,000 EVs in Mexico by 2025, despite potential 200% tariffs on Chinese-made cars proposed by Donald Trump. The company plans to announce its first Mexican factory location by year-end, initially producing 150,000 vehicles. BYD is seeking tariff relief and exploring global markets amid trade challenges.

Portfolio Pulse from Benzinga Neuro

October 09, 2024 | 10:19 am

SDGR

Schrödinger announced that new preclinical data on its investigational Wee1/myt1 inhibitor, SGR-3515, and its PRMT5-MTA inhibitor program will be presented at the EORTC-NCI-AACR Symposium.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:12 am

SFM

Sprouts Farmers Market has launched a new exclusive line called Real Root by Sprouts, featuring over 130 premium body care, personal care, and home fragrance items. This initiative aims to promote a healthier lifestyle among its customers.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 10:11 am